» Articles » PMID: 25560182

The Rise in Appendiceal Cancer Incidence: 2000-2009

Overview
Specialty Gastroenterology
Date 2015 Jan 7
PMID 25560182
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Appendiceal cancer is a rare and potentially aggressive malignancy. The objectives of this study were to characterize secular demographic patterns of disease and to determine survival by using a population-based data source.

Methods: Using the Surveillance, Epidemiology, and End Results database, we conducted a retrospective cohort analysis of patients treated from 2000-2009.

Results: We identified 4765 patients with appendiceal cancer. The incidence of appendiceal cancer increased by 54% from 2000 (0.63 per 100,000) to 2009 (0.97 per 100,000 population). Incidence rates increased across all tumor types, stages, age groups, and gender. The most common malignancies were mucinous adenocarcinoma (38%), followed by carcinoids (28%), adenocarcinoma-not otherwise specified (NOS) (27%), and signet ring cell adenocarcinoma (7%). Larger tumor size and older patient age were significantly associated with higher relative odds of distant disease at diagnosis (P < 0.0001). Patient and demographic characteristics were significantly associated with higher relative hazard of death (P < 0.0001).

Conclusions: Although appendiceal cancer is rare, the incidence increased significantly in the USA from 2000 to 2009. The cause of this trend is not obvious. We did not observe increases differentially associated with stage, histology, or demographic characteristics. Further investigation is needed to examine factors underlying this increase.

Citing Articles

Defining a 'cells to society' research framework for appendiceal tumours.

Holowatyj A, Overman M, Votanopoulos K, Lowy A, Wagner P, Washington M Nat Rev Cancer. 2025; .

PMID: 39979656 DOI: 10.1038/s41568-024-00788-2.


Mucinous adenocarcinoma of the appendix presenting as acute appendicitis: a case report.

Al Salkhadi A, Al Salkhadi M, Hasan A J Surg Case Rep. 2024; 2024(11):rjae713.

PMID: 39559167 PMC: 11573437. DOI: 10.1093/jscr/rjae713.


Ten-Year Outcome of a Randomized Trial: Cytoreduction and HIPEC with Mitomycin C Versus Oxaliplatin for Appendiceal Neoplasm with Peritoneal Dissemination.

Levine E, Cos H, Votanopoulos K, Shen P, Russell G, Mansfield P Ann Surg Oncol. 2024; 32(2):679-686.

PMID: 39531120 PMC: 11698756. DOI: 10.1245/s10434-024-16441-z.


Negative Impact of Systemic Therapy on Survival in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Low-Grade Metastatic Appendiceal Adenocarcinoma.

Stillman M, Somasundar P, Espat N, Calvino A, Kwon S Ann Surg Oncol. 2024; 32(1):221-229.

PMID: 39500859 DOI: 10.1245/s10434-024-16443-x.


Appendiceal adenocarcinoma associated with Amyand's hernia: a case report.

Momota K, Shibata K, Miyake H, Nagai H, Yoshioka Y, Yuasa N Nagoya J Med Sci. 2024; 86(3):514-523.

PMID: 39355369 PMC: 11439601. DOI: 10.18999/nagjms.86.3.514.


References
1.
Andreyev H, Norman A, Oates J, Cunningham D . Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer. 1998; 34(4):503-9. DOI: 10.1016/s0959-8049(97)10090-9. View

2.
Modlin I, Sandor A . An analysis of 8305 cases of carcinoid tumors. Cancer. 1997; 79(4):813-29. DOI: 10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2. View

3.
Groth S, Virnig B, Al-Refaie W, Jarosek S, Jensen E, Tuttle T . Appendiceal carcinoid tumors: Predictors of lymph node metastasis and the impact of right hemicolectomy on survival. J Surg Oncol. 2010; 103(1):39-45. DOI: 10.1002/jso.21764. View

4.
Trivedi A, Levine E, Mishra G . Adenocarcinoma of the appendix is rarely detected by colonoscopy. J Gastrointest Surg. 2008; 13(4):668-75. DOI: 10.1007/s11605-008-0774-6. View

5.
Misdraji J, Yantiss R, Graeme-Cook F, Balis U, Young R . Appendiceal mucinous neoplasms: a clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003; 27(8):1089-103. DOI: 10.1097/00000478-200308000-00006. View